PrognomIQ, Inc. announced that it will issue 16,537,834 series C preferred shares at issue price of $3.06 per share for the gross proceeds $50,605,772.04 in funding on February 16, 2022. The shares carry non-cumulative dividend value of $0.1836 per annum per share. The shares will be convertible in common shares at a price of $3.06 per share.